Exploring the application of comprehensive genomic profiling in oncology therapy development
eurofins
America/Chicago UTC -5
Description
Comprehensive genomic profiling (CGP) is a method of testing that uses next-generation sequencing (NGS) to detect multiple genomic alterations (mutations and gene rearrangements) known to drive cancer growth. These alterations (biomarkers) have been shown to correlate with response to therapy, making them useful as an aid to more effective trial design and potentially improved outcomes.
What will you learn?
-What are comprehensive genomic profiles (CGP)?
-The four classes of genomic alterations known to drive cancer.
-How CGP can contribute to cancer diagnosis and the precision medicine approach to treatment decisions.
-How researchers are exploiting this technology to help reshape oncology trials and design more personalized therapies.
What are comprehensive genomic profiles (CGP)?, The four classes of genomic alterations known to drive cancer, How CGP can contribute to cancer diagnosis and the precision medicine approach to treatment decisions, How researchers are exploiting this technology to help reshape oncology trials and design more personalized therapies
Inglês
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Speakers
Karina Eterovic
Link to the Event
Banner to the Event
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.